The use of cell salvage in adult cardiac surgery at Queen Alia Heart Institute


  • Dya D. Alsmadi Department of Cardiac Anaesthesia, QAHI, Amman, Jordan
  • Abdallah Alhadidi Department of Cardiac Anaesthesia, QAHI, Amman, Jordan
  • Ahmad Alawamleh Department of Cardiac Anaesthesia, QAHI, Amman, Jordan
  • Suhaib Alghawanmeh Department of Cardiac Anaesthesia, QAHI, Amman, Jordan
  • Wael Alshobaki Department of Cardiac Anaesthesia, QAHI, Amman, Jordan
  • Ashraf F. Mohd Department of Cardiac Anaesthesia, QAHI, Amman, Jordan



Anaesthesia, Cardiac surgery, Cell saver, Haematocrit, Hospitalisation, Transfusion


Background: Objective of the study was to determine the incidence of use cell salvage, indications, efficacy in blood conservation and benefits on recovery after adult cardiac surgery.

Methods: This is an observational analysis of adult cardiac surgical patients presenting for cardiac surgery at Queen Alia Heart Institute in the period between September 2023 and December 2023. Patients’ demographics, type of surgery (cardiac pathology), comorbidities, preoperative and postoperative laboratory results, blood transfusion requirements, extubation and intensive care unit (ICU) length of stay were recorded and statistically analysed to determine the effectiveness of cell salvage. Patients were divided into two groups: The cell saver group and the no cell saver group for comparison.

Results: Data from 141 adult cardiac surgeries is included in this analysis. Indications for cell saver use were recent anticoagulation (41.4%), more complex surgery (20.7%), high risk of bleeding (13.8%), preoperative anaemia (6.9%), intraoperative major bleeding (6.9%), coagulopathy (6.9%) and rare patient blood type (3.45%). Patients from the cell saver group required blood transfusion 2.1% more than the no cell saver group. There was no significant difference in the length of hospitalization between those who had and those who had not cell saver used during surgery (11.9 and 12 days, respectively).

Conclusions: Cell saver was used in one fifth of adult cardiac surgeries. Most common indications for cell saver use during cardiac surgery were recent anticoagulation and more complicated cardiac surgery. The use of cell saver had no impact on postoperative haematocrit or overall time of hospitalization.



Wang G, Bainbridge D, Martin J, Cheng D. The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesth Analg. 2009;109(2):320-30.

Nathan M, Tishler B, Gauvreau K, Matte GS, Howe RJ, Durham L, et al. A red cell preservation strategy reduces postoperative transfusions in pediatric heart surgery patients. Paediatr Anaesth. 2018;28(5):450-7.

Spiess BD. Blood transfusion: the silent epidemic. Ann Thorac Surg. 2001;72(5):S1832-7.

Engoren MC, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg. 2002;74(4):1180-6.

Blundell J. Experiments on the Transfusion of Blood by the Syringe. Med Chir Trans. 1818;9(Pt 1):56-92.

Konig G, Waters JH. Washing and filtering of cell-salvaged blood - does it make autotransfusion safer? Transfus Altern Transfus Med. 2012;12(3-4):78-87.

Allam J, Cox M, Yentis SM. Cell salvage in obstetrics. Int J Obstet Anesth. 2008;17(1):37-45.

Amand T, Pincemail J, Blaffart F, Larbuisson R, Limet R, Defraigne JO. Levels of inflammatory markers in the blood processed by autotransfusion devices during cardiac surgery associated with cardiopulmonary bypass circuit. Perfusion. 2002;17(2):117-23.

Lau K, Shah H, Kelleher A, Moat N. Coronary artery surgery: cardiotomy suction or cell salvage? J Cardiothorac Surg. 2007;2:46.

Ashworth A, Klein AA. Cell salvage as part of a blood conservation strategy in anaesthesia. Br J Anaesth. 2010;105(4):401-16.

O'Carroll-Kuehn BU, Meeran H. Management of coagulation during cardiopulmonary bypass. Continuing Education in Anaesthesia Critical Care & Pain. 2007;7(6):195-8.

Tan NL, Corbineau H, Phu BD, Verhoye JP. Is a cell saver necessary in off-pump coronary artery bypass surgery? Asian Cardiovasc Thorac Ann. 2012;20(5):539-43.

Ackfeld T, Schmutz T, Guechi Y, Le Terrier C. Blood Transfusion Reactions-A Comprehensive Review of the Literature including a Swiss Perspective. J Clin Med. 2022;11(10):2859.

Jewell AE, Akowuah EF, Suvarna SK, Braidley P, Hopkinson D, Cooper G. A prospective randomised comparison of cardiotomy suction and cell saver for recycling shed blood during cardiac surgery. Eur J Cardiothorac Surg. 2003;23(4):633-6.

Attaran S, McIlroy D, Fabri BM, Pullan MD. The use of cell salvage in routine cardiac surgery is ineffective and not cost-effective and should be reserved for selected cases. Interact Cardiovasc Thorac Surg. 2011;12(5):824-6.

Klein AA, Nashef SA, Sharples L, Bottrill F, Dyer M, Armstrong J, Vuylsteke A. A randomized controlled trial of cell salvage in routine cardiac surgery. Anesth Analg. 2008;107(5):1487-95.

Côté CL, Yip AM, MacLeod JB, O'Reilly B, Murray J, Ouzounian M, et al. Efficacy of intraoperative cell salvage in decreasing perioperative blood transfusion rates in first-time cardiac surgery patients: a retrospective study. Can J Surg. 2016;59(5):330-6.

Murphy GJ, Rogers CS, Lansdowne WB, Channon I, Alwair H, Cohen A, et al. Safety, efficacy, and cost of intraoperative cell salvage and autotransfusion after off-pump coronary artery bypass surgery: a randomized trial. J Thorac Cardiovasc Surg. 2005;130(1):20-8.

Al Khabori M, Al Riyami A, Siddiqi MS, Sarfaraz ZK, Ziadinov E, Al Sabti H. Impact of cell saver during cardiac surgery on blood transfusion requirements: a systematic review and meta-analysis. Vox Sang. 2019;114(6):553-65.

Neef V, Vo L, Herrmann E, Triphaus C, Judd L, Winter A, et al. The association between intraoperative cell salvage and red blood cell transfusion in cardiac surgery - an observational study in a patient blood management centre. Anaesthesiol Intensive Ther. 2021;53(1):1-9.






Original Research Articles